At what enterprise value was AMEDES acquired in 2015?

During the acquisition of AMEDES by ANTIN INFRASTRUCTURE in 2015, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of AMEDES when it was acquired by ANTIN INFRASTRUCTURE?

The estimated EV/EBITDA multiple for AMEDES is in the range of 5x - 12x.

When was AMEDES acquired by ANTIN INFRASTRUCTURE?

AMEDES was acquired by ANTIN INFRASTRUCTURE in 2015.

What was the EBITDA of AMEDES during the acquisition?

AMEDES's EBITDA is estimated to be in the range of 50M - 100M EUR.

How is the data for the AMEDES acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the AMEDES deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.antin-ip.com/wp-content/uploads/2023/01/InfraNews-Antin-buys-medical-diagnostics-business.pdf

← DATABASE

Home Database Healthcare & PharmaAMEDES

07/2015

AMEDES acquired by ANTIN INFRASTRUCTURE

GERMANY Health Providers / Healthcare Facilities / Labs (Biology) EV 500M - 1.5b EUR

Context

Antin Infrastructure Partners acquired a majority stake in Amedes Group from General Atlantic. The transaction provided an exit for General Atlantic, which had owned the asset since 2007 and tripled its revenues through a buy-and-build strategy (30+ acquisitions). For Antin, this investment represents a classic "infrastructure" play in the healthcare sector: high recurring revenue (almost 100% repeat usage) due to sticky relationships between doctors and labs, and low volume volatility.

AMEDES, which reported an EBITDA margin of in 2016, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Amedes is one of the leading platforms for medical diagnostics in Germany. It has 35 laboratories and 27 practices across Germany and Belgium.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2016

2015

Other operations with AMEDES

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
07/2021	OMERS	AMEDES	GERMANY	Labs (Biology)

REFERENCES

Valuation range: EV 500M - 1.5b EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of AMEDES by ANTIN INFRASTRUCTURE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: antin infrastructure